To the Editor: Posner-Schlossmann syndrome (PSS), also known as glaucomatocyclitic crisis, is characterized by acute, unilateral, recurrent attacks of ocular hypertension, mild non-granulomatous anterior uveitis (AU),...To the Editor: Posner-Schlossmann syndrome (PSS), also known as glaucomatocyclitic crisis, is characterized by acute, unilateral, recurrent attacks of ocular hypertension, mild non-granulomatous anterior uveitis (AU), and spontaneous recovery. However, the etiology of this disease is unknown. Many mechanisms have been proposed including viral infection, autoimmune, autonomic dysregulation, allergic conditions and vascular endothelial dysfunction.[1] Topical anti-hypertensives and anti-inflammatory medications are typically prescribed to combat this disease. Repeated attacks may lead to longterm glaucomatous optic nerve damage over 5–10 years after the first episode. Because the pathophysiology is not completely understood, treatment and prevention of recurrences has proven to be difficult.展开更多
文摘To the Editor: Posner-Schlossmann syndrome (PSS), also known as glaucomatocyclitic crisis, is characterized by acute, unilateral, recurrent attacks of ocular hypertension, mild non-granulomatous anterior uveitis (AU), and spontaneous recovery. However, the etiology of this disease is unknown. Many mechanisms have been proposed including viral infection, autoimmune, autonomic dysregulation, allergic conditions and vascular endothelial dysfunction.[1] Topical anti-hypertensives and anti-inflammatory medications are typically prescribed to combat this disease. Repeated attacks may lead to longterm glaucomatous optic nerve damage over 5–10 years after the first episode. Because the pathophysiology is not completely understood, treatment and prevention of recurrences has proven to be difficult.
